Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Research Network

Collaboration Network

22 collaborators·25 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of KidneyOvary CancerBrain and Central Nervous System Tumors+2 more

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)+1 more
Similarity Score25%

Roger Stupp, MD

Centre Hospitalier Universitaire Vaudois

Related
7 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsMetastatic Cancer

Worked with same sponsors:

European Organisation for Research and Treatment of Cancer - EORTCNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score24%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Related
12 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsMetastatic Cancer

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)+4 more
Collaborated on 1 trial
Similarity Score24%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Melanoma (Skin)Cancer of KidneyOvary Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerOvary CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Ovary CancerMetastatic CancerSarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Ovary CancerMelanoma (Skin)Cancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Geoffrey R. Barger, MD

Barbara Ann Karmanos Cancer Institute

Related
3 trials

Shared therapeutic areas:

Brain and Central Nervous System Tumors

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)+4 more
Collaborated on 1 trial
Similarity Score14%

Mark R. Gilbert, MD

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Brain and Central Nervous System Tumors

Worked with same sponsors:

European Organisation for Research and Treatment of Cancer - EORTCNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score14%

Jan C. Buckner, MD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Brain and Central Nervous System Tumors

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)+4 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00003308Phase 2StudyChair

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Completed
NCT00003375Phase 2/3StudyChair

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Brain and Central Nervous System Tumors
Completed
NCT00304031Phase 3StudyChair

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Brain and Central Nervous System Tumors
Completed

All 3 trials loaded